Below are the most recent publications written about "Uterine Cervical Neoplasms" by people in Profiles.
-
Mix J, Saraiya M, Hallowell BD, Befano B, Cheung LC, Unger ER, Gargano JW, Markowitz LE, Castle PE, Raine-Bennett T, Walker J, Zuna R, Schiffman M, Wentzensen N, Gage JC. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. J Natl Cancer Inst. 2022 Jun 13; 114(6):845-853.
-
Gogoi RP, Wallbillich JJ, Winer I, Morris R, Ritchie C, Larson S, Walker J, Bickmore T, Spencer E, Jang H, Kim S, Phalore J, Bui TC. Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education. Obstet Gynecol. 2022 May 01; 139(5):913-915.
-
Garg A, Galvin AM, Matthes S, Maness SB, Thompson EL. The Connection Between Social Determinants of Health and Human Papillomavirus Testing Knowledge Among Women in the USA. J Cancer Educ. 2022 02; 37(1):148-154.
-
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 09; 162(3):532-538.
-
Kiff JM, Cotter M, Munro EG, Leonard ME, Morgan TK, Bruegl AS. Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening? J Womens Health (Larchmt). 2021 07; 30(7):972-978.
-
Cimic A, Vranic S, Arguello D, Contreras E, Gatalica Z, Swensen J. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix. Appl Immunohistochem Mol Morphol. 2021 04 01; 29(4):299-304.
-
Wentzensen N, Lahrmann B, Clarke MA, Kinney W, Tokugawa D, Poitras N, Locke A, Bartels L, Krauthoff A, Walker J, Zuna R, Grewal KK, Goldhoff PE, Kingery JD, Castle PE, Schiffman M, Lorey TS, Grabe N. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. J Natl Cancer Inst. 2021 01 04; 113(1):72-79.
-
Bhochhibhoya S, Dobbs PD, Maness SB. Interventions using mHealth strategies to improve screening rates of cervical cancer: A scoping review. Prev Med. 2021 02; 143:106387.
-
Chen X, Liu W, Thai TC, Castellano T, Gunderson CC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients. Comput Methods Programs Biomed. 2020 Dec; 197:105759.
-
Rischin D, Gil-Martin M, González-Martin A, Braña I, Hou JY, Cho D, Falchook GS, Formenti S, Jabbour S, Moore K, Naing A, Papadopoulos KP, Baranda J, Fury W, Feng M, Stankevich E, Li J, Yama-Dang NA, Yoo SY, Lowy I, Mathias M, Fury MG. PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. Gynecol Oncol. 2020 11; 159(2):322-328.